标题 |
Lenvatinib (len) plus pembrolizumab (pembro)for patients (pts) with advanced melanoma and confirmed progression on a PD-1 or PD-LI inhibitor: Updated findings of LEAP-004
Lenvatinib(len)联合pembrolizumab(pembro)治疗晚期黑色素瘤患者(pt)并确认PD-1或PD-LI抑制剂的进展:LEAP-004的最新发现
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | ARANCE AM, DE LA CRUZ-MERINO L, PETRELLA TM, et al. Lenvatinib (len) plus pembrolizumab (pembro)for patients (pts) with advanced melanoma and confirmed progression on a PD-1 or PD-LI inhibitor: Updated findings of LEAP-004. J Clin Oncol, 2021, 39 (15_suppl): 9504. |
求助人 | |
下载 |